Alere i™ Influenza A & B delivers molecular flu results in less than 15 minutes on our unique Alere i platform; making it significantly faster than other molecular methods and more accurate than conventional rapid tests. Rapid diagnostic tests with increased sensitivity are essential for the reliable detection of influenza A and B and enable immediate, effective treatment decisions. 1 Williams, KM, Jackson MA, Hamilton M. Rapid Diagnostic Testing for URIs in Children: Impact on Physician Decision Making and Cost. Infect. Med. 19(3): 109? 111, 2002 Benefits Offers exceptional performance Eliminates interpretation and transcription errors Gives you the confidence to make clinical decisions sooner Facilitates effective patient management Enables prompt initiation of infection control measures Aids targeted antiviral therapy and Antimicrobial Stewardship Find out more at alere-i.com. Specifications Highly accurate results in 15 minutes Specimen types: Nasal Swab and Viral Transport Media (VTM) Small footprint enables ease of use at point of care Simple operation via visual touchscreen SKU NAT-000 Alere™ i Instrument 425-000 Alere™ i Influenza A & B 24 Test Kit 425-080 Alere™ i Influenza A & B Control Swab Kit EQ001001 Alere™ i Barcode Scanner 55115 Alere™ i Universal Printer